Implanet S.A. (ALIMP.PA)

EUR 0.1

(-6.64%)

Revenue Summary of Implanet S.A.

  • Implanet S.A.'s latest annual revenue in 2023 was 7.44 Million EUR , down -7.24% from previous year.
  • Implanet S.A.'s latest quarterly revenue in 2024 Q2 was 4.11 Million EUR , down 0.0% from previous quarter.
  • Implanet S.A. reported a annual revenue of 8.02 Million EUR in annual revenue 2022, up 30.75% from previous year.
  • Implanet S.A. reported a annual revenue of 6.14 Million EUR in annual revenue 2021, up 57.76% from previous year.
  • Implanet S.A. reported a quarterly revenue of 4.26 Million EUR for 2023 Q2, down 0.0% from previous quarter.
  • Implanet S.A. reported a quarterly revenue of 3.17 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Revenue Chart of Implanet S.A. (2023 - 2012)

Historical Annual Revenue of Implanet S.A. (2023 - 2012)

Year Revenue Revenue Growth
2023 7.44 Million EUR -7.24%
2022 8.02 Million EUR 30.75%
2021 6.14 Million EUR 57.76%
2020 3.89 Million EUR -47.46%
2019 7.4 Million EUR 10.22%
2018 6.72 Million EUR -14.3%
2017 7.84 Million EUR 0.2%
2016 7.82 Million EUR 17.61%
2015 6.65 Million EUR -5.47%
2014 7.03 Million EUR 5.2%
2013 6.69 Million EUR 0.66%
2012 6.64 Million EUR 0.0%

Peer Revenue Comparison of Implanet S.A.

Name Revenue Revenue Difference
Affluent Medical SA 1.22 Million EUR -508.415%
Bluelinea Société Anonyme 9826.00 EUR -75688.724%
Carmat SA 2.84 Million EUR -161.482%
Diagnostic Medical Systems S.A. 42.15 Million EUR 82.333%
Euromedis Groupe 37.42 Million EUR 80.103%
Eurobio Scientific Société anonyme 130.64 Million EUR 94.3%
Ikonisys S.A. 448.55 Thousand EUR -1560.213%
Median Technologies SA 22.22 Million EUR 66.494%
SpineGuard SA 4.31 Million EUR -72.672%
Theraclion SA 1.82 Million EUR -308.677%
Euroapi S.A. 1.01 Billion EUR 99.269%
Guerbet SA 785.69 Million EUR 99.052%